Infusion Unit Therapies In Westchester

Our infusion unit offers intravenous therapies for immunologic and autoimmune disorders. We have been providing this service to patients in Westchester County since 1999, when Remicade (infliximab) was first approved by the FDA for the treatment of Rheumatoid Arthritis. Since then, numerous additional “biologic” agents  and advanced therapies have been made available and we offer many of these in our center. All the therapies we offer are FDA approved.

Our facility is very attractive to patients. The setting is comfortable and private. Our office is well located, easy to get to, and provides ample free parking.  We use recliner infusion chairs and provide wireless internet access and cable TV in each private infusion room. Patients are monitored closely by our infusion nurse. Many patients prefer this setting to hospital based treatment units, where delays are common and the setting often impersonal.

Some of our patients are under the care of physicians elsewhere, but take advantage of the convenience, efficiency,  and comfort of our setting. We are more than happy to work with your treating physician to facilitate the provision of the treatment you may require. Typically, these treatments are quite costly and require support from your health insurance program.  Our team is quite experienced and will make every effort to obtain approval and payment for treatment, as well as seeking additional sources of support for your prescribed therapy.

We do not participate with any insurance (other than Medicare). Our office will obtain all the necessary pre-authorizations for all covered services provided. We will submit all claims to your insurance for you.

Here Are Some Of The Conditions We Often Treat In The Infusion Center:

  • Rheumatoid Arthritis
  • Systemic Lupus
  • Sjogren’s Syndrome
  • Polymyositis/Dermatomyositis
  • Ankylosing Spondylitis
  • Psoriasis/Psoriatic Arthritis
  • Systemic Vasculitis
  • Temporal Arteritis
  • Gout
  • Osteoporosis
  • Hypogammaglobulinemia
  • Common Variable Immunodeficiency
  • Crohn’s Disease
  • Ulcerative Colitis
  • Multiple Sclerosis

The Following Is A List Of The Treatments We Currently Offer:

  • Remicade (infliximab)
  • Actemra (tocilizumab)
  • Orencia (abatacept)
  • Ocrevus (ocrelizumab)
  • Simponi Aria (golimumab)
  • Rituxan (rituximab)
  • Intravenous Immune Globulin (gamma globulin)
  • Reclast (zoledronic acid)
  • Prolia (denosumab)
  • Entyvio (vedolizumab)
  • Tysabri (natalizumab)
  • Krystexxa (pegloticase)